Oxurion NV (OXUR.BR) Comparison with companies in other sectors?

Oxurion NV has a share price of 25.36M. You can analyze Oxurion NV (OXUR.BR) competitors across different market sectors through stock heatmaps.

What are OXUR.BR's NET and operating margins?

Oxurion NV (OXUR.BR) operating margin is around -1064.67, and net profit margin is approximately 39.67 as of the latest reports.

In what way does OXUR.BR's earnings per share (EPS) trend reflect its financial momentum?

Oxurion NV (OXUR.BR) EPS is 97.53 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Oxurion NV is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Oxurion NV?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Oxurion NV like P/E which is 0.35, P/B which is -0.00, and PEG which is 0.003. Compare them with sector averages to evaluate if the stock is priced fairly.

Oxurion NV

OXUR.BR•EURONEXT

Healthcare

Biotechnology

€0.03

€0.001(1.82%)

Oxurion NV (OXUR.BR) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$97.53

P/E Ratio

ROE

-0.01%

Net Margin

39.67%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$852.13K

Shares OutstandingTotal number of shares issued

$25.36M

Book Value/ShareNet worth per share

$-9.00

Revenue/ShareAnnual revenue per share

$0.002

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$97.53

Net MarginNet income as percentage of revenue

3966.67%

Operating MarginOperating income as percentage of revenue

-106466.67%

ROEReturn on shareholders' equity

-0.92%

ROAReturn on total assets

2.09%

ROCEReturn on capital employed

29.23%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.80

Cash/ShareCash and equivalents per share

$0.37

FCF YieldFree cash flow as percentage of market cap

-259.47%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for OXUR.BRFinancial Ratios Analysis details for OXUR.BR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for OXUR.BRSector Benchmarking details for OXUR.BR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Oxurion NV Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Oxurion NV. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Oxurion NV's unique business strengths and challenges.

Key Financial Metrics for Oxurion NV

For Oxurion NV, essential financial indicators include EPS 97.53, PE -, and ROE -0.01. These key ratios reveal insights into Oxurion NV's profitability, valuation, and operational health. Understanding these metrics enables you to compare Oxurion NV with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Oxurion NV

Metrics like Net Margin 3966.67% and ROA 2.09% shed light on how well Oxurion NV is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Oxurion NV can sustain its operations and continue growing in the future.

Valuation and Market Position of Oxurion NV

Using ratios such as P/B Ratio -0.00 and PEG Ratio 0.003, investors can assess whether Oxurion NV is appropriately valued based on its financials and growth potential. These figures, combined with Oxurion NV's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Oxurion NV

Financial health indicators, such as Debt/Equity Ratio -1.02 and Cash Flow $-1.80, provide a snapshot of Oxurion NV's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Oxurion NV, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Oxurion NV

Investing in Oxurion NV based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Oxurion NV focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;